DBV Technologies
16 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers) (NCT07003919) | DBV Technologies | 2025-06-24 |
| Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Children 4-7 Years of Age (NCT05741476) | DBV Technologies | 2023-02-21 |
| Diagnostic Accuracy and Safety of DBV1605 for the Diagnosis of Non-IgE Mediated Cow's Milk Allergy in Children (NCT04492683) | DBV Technologies | 2020-08-28 |
| Follow-up of the EPITOPE Study to Evaluate Long-term Efficacy and Safety of DBV712 in Young Children (NCT03859700) | DBV Technologies | 2018-12-06 |
| A Study to Assess the Biological Potency of Peanut Allergen Extract in Adolescent and Adult Peanut Allergic Subjects (NCT03352726) | DBV Technologies | 2017-11-24 |
Track DBV Technologies automatically
Every clearance here is in the API, with alerts when new ones post.